tirzepatide news outperformed semaglutide weight-loss drug results in real world patients, study shows Tirzepatide has been officially removed

A fuller explanation of diffuse hair loss can be found in our overview of the connection between weight and hair loss

Dose adjustments might land on 3mg or 6mg

In a recent study published in Scientific Reports, researchers evaluated the impact of semaglutide [a glucagon-like peptide-1 (GLP-1) receptor agonist] and tirzepatide [a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist] medications on alcohol consumption among obese individuals

Three generations of incretin agonists: understanding the evolution of retatrutide vs tirzepatide vs semaglutide The recent pharmacological history of obesity treatment can be summarized in three successive stages, each adding a new mechanism to the previous one